Chia Tai Tianqing Pharmaceutical (Guangzhou) Co., Ltd.

Clinical trials sponsored by Chia Tai Tianqing Pharmaceutical (Guangzhou) Co., Ltd., explained in plain language.

Now part of Sino Biopharmaceutical Limited 1177 HKEX

A subsidiary of Sino Biopharmaceutical focused on pharmaceutical development.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Terminated 1

New COPD inhaler spray tested in healthy volunteers – no cure expected

Knowledge-focused Stopped early

This early-stage study tests whether a new inhaler spray called TQC3302 is safe and how it moves through the body. It involves 57 healthy adults in China, not people with lung disease. The goal is to check for side effects and measure drug levels, not to treat any condition.

Phase 1 • Sponsor: Chia Tai Tianqing Pharmaceutical (Guangzhou) Co., Ltd. • Aim: Knowledge-focused

Last updated Aug 29, 2026 00:00 UTC

Chia Tai Tianqing Pharmaceutical (Guangzhou) Co., Ltd.

New COPD inhaler spray tested in healthy volunteers – no cure expected